Universe Pharmaceuticals (UPC) Enterprise Value: 2020-2024
- Universe Pharmaceuticals' Enterprise Value fell 3917.49% to -$30.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$63.5 million, marking a year-over-year decrease of 6.64%. This contributed to the annual value of -$30.0 million for FY2024, which is 3917.49% down from last year.
- Per Universe Pharmaceuticals' latest filing, its Enterprise Value stood at -$30.0 million for Q3 2024, which was down 344.83% from -$6.7 million recorded in Q1 2024.
- In the past 5 years, Universe Pharmaceuticals' Enterprise Value registered a high of $30.1 million during Q3 2021, and its lowest value of -$30.0 million during Q3 2024.
- In the last 3 years, Universe Pharmaceuticals' Enterprise Value had a median value of -$6.5 million in 2022 and averaged -$7.3 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Enterprise Value skyrocketed by 398.93% in 2021 and then plummeted by 3,917.49% in 2024.
- Universe Pharmaceuticals' Enterprise Value (Quarterly) stood at -$10.1 million in 2020, then spiked by 398.93% to $30.1 million in 2021, then plummeted by 121.86% to -$6.6 million in 2022, then soared by 111.95% to $785,488 in 2023, then tumbled by 3,917.49% to -$30.0 million in 2024.
- Its Enterprise Value stands at -$30.0 million for Q3 2024, versus -$6.7 million for Q1 2024 and $785,488 for Q3 2023.
